Pointe Capital Management’s MetLife MET Stock Holding History

Pointe Capital Management’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-675	Closed	-$39.1K	–	297
2023 Q1	$39.1K	Buy	+675	New	+$45.6K	0.03%	249

Other funds holding MET

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Pointe Capital Management's MET Position: Q2 2023 in Review

Pointe Capital Management sold out of MetLife (MET) in Q2 2023, closing a stake of 675 shares — an estimated $39.1K sold.

Pointe Capital Management first reported a position in MET in Q1 2023 and held it in 1 quarter. The position peaked at $39.1K in Q1 2023. 1,170 funds tracked by Wall St. Rank hold MET as of Q2 2023.

Pointe Capital Management reported no remaining MetLife position as of Q2 2023 after selling out during the quarter.
Pointe Capital Management sold 675 MetLife shares in Q2 2023, an estimated $39.1K.
Pointe Capital Management first reported a position in MetLife in Q1 2023 and held it in 1 quarter.
Pointe Capital Management's MetLife position peaked at $39.1K in Q1 2023.
1,170 funds tracked by Wall St. Rank held MetLife as of Q2 2023.

Based on Pointe Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.